Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 108.20
+0.20 (0.19%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Hereditary Diseases | 130.14M |
Log In |
Log In |
Log In |
Log In |
| Hereditary Diseases Growth | 18.26% |
Log In |
Log In |
Log In |
Log In |
| Oncology | 49.89M |
Log In |
Log In |
Log In |
Log In |
| Oncology Growth | 47.33% |
Log In |
Log In |
Log In |
Log In |
| Transplantation | 36.87M |
Log In |
Log In |
Log In |
Log In |
| Transplantation Growth | 45.20% |
Log In |
Log In |
Log In |
Log In |
| Genetic Test Kits | - |
Log In |
Log In |
Log In |
Log In |
| Genetic Test Kits Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Italy | 87.50M |
Log In |
Log In |
Log In |
Log In |
| Europe, Middle East and Africa | 62.10M |
Log In |
Log In |
Log In |
Log In |
| Europe, Middle East and Africa Growth | -55.45% |
Log In |
Log In |
Log In |
Log In |
| Germany | 31.30M |
Log In |
Log In |
Log In |
Log In |
| North and South America | 17.90M |
Log In |
Log In |
Log In |
Log In |
| North and South America Growth | 29.71% |
Log In |
Log In |
Log In |
Log In |
| Sweden | 11.10M |
Log In |
Log In |
Log In |
Log In |
| Sweden Growth | 11.00% |
Log In |
Log In |
Log In |
Log In |
| Asia | 7.00M |
Log In |
Log In |
Log In |
Log In |
| Asia Growth | 14.75% |
Log In |
Log In |
Log In |
Log In |